Global Human Coagulation Factor VIII Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, The global Human Coagulation Factor VIII market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Coagulation Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Coagulation Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Human Coagulation Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Coagulation Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Coagulation Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Coagulation Factor VIII sales, projected growth trends, production technology, application and end-user industry.
Human Coagulation Factor VIII segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Coagulation Factor VIII market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.
According to APO Research, The global Human Coagulation Factor VIII market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Human Coagulation Factor VIII is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Human Coagulation Factor VIII include Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk and Greencross, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Human Coagulation Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Coagulation Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Human Coagulation Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Coagulation Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Coagulation Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Coagulation Factor VIII sales, projected growth trends, production technology, application and end-user industry.
Human Coagulation Factor VIII segment by Company
- Shire (Baxter)
- Bayer
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- NovoNordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- Recombinant Factor VIII
- Plasma-derived Factor VIII
- Hemophilia A
- Spontanous / Trauma
- Surgical
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Human Coagulation Factor VIII market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Human Coagulation Factor VIII Market Size, 2019 VS 2023 VS 2030
1.3 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts (2019-2030)
1.4 Global Human Coagulation Factor VIII Sales Estimates and Forecasts (2019-2030)
1.5 Global Human Coagulation Factor VIII Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL HUMAN COAGULATION FACTOR VIII MARKET DYNAMICS
2.1 Human Coagulation Factor VIII Industry Trends
2.2 Human Coagulation Factor VIII Industry Drivers
2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
2.4 Human Coagulation Factor VIII Industry Restraints
3 HUMAN COAGULATION FACTOR VIII MARKET BY MANUFACTURERS
3.1 Global Human Coagulation Factor VIII Revenue by Manufacturers (2019-2024)
3.2 Global Human Coagulation Factor VIII Sales by Manufacturers (2019-2024)
3.3 Global Human Coagulation Factor VIII Average Sales Price by Manufacturers (2019-2024)
3.4 Global Human Coagulation Factor VIII Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
3.7 Global Human Coagulation Factor VIII Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Coagulation Factor VIII Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2023
3.8.3 2023 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier
4 HUMAN COAGULATION FACTOR VIII MARKET BY TYPE
4.1 Human Coagulation Factor VIII Type Introduction
4.1.1 Recombinant Factor VIII
4.1.2 Plasma-derived Factor VIII
4.2 Global Human Coagulation Factor VIII Sales by Type
4.2.1 Global Human Coagulation Factor VIII Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Coagulation Factor VIII Sales by Type (2019-2030)
4.2.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)
4.3 Global Human Coagulation Factor VIII Revenue by Type
4.3.1 Global Human Coagulation Factor VIII Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Coagulation Factor VIII Revenue by Type (2019-2030)
4.3.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)
5 HUMAN COAGULATION FACTOR VIII MARKET BY APPLICATION
5.1 Human Coagulation Factor VIII Application Introduction
5.1.1 Hemophilia A
5.1.2 Spontanous / Trauma
5.1.3 Surgical
5.1.4 Other
5.2 Global Human Coagulation Factor VIII Sales by Application
5.2.1 Global Human Coagulation Factor VIII Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Coagulation Factor VIII Sales by Application (2019-2030)
5.2.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)
5.3 Global Human Coagulation Factor VIII Revenue by Application
5.3.1 Global Human Coagulation Factor VIII Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Coagulation Factor VIII Revenue by Application (2019-2030)
5.3.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)
6 GLOBAL HUMAN COAGULATION FACTOR VIII SALES BY REGION
6.1 Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Coagulation Factor VIII Sales by Region (2019-2030)
6.2.1 Global Human Coagulation Factor VIII Sales by Region (2019-2024)
6.2.2 Global Human Coagulation Factor VIII Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Human Coagulation Factor VIII Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Human Coagulation Factor VIII Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Human Coagulation Factor VIII Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Human Coagulation Factor VIII Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL HUMAN COAGULATION FACTOR VIII REVENUE BY REGION
7.1 Global Human Coagulation Factor VIII Revenue by Region
7.1.1 Global Human Coagulation Factor VIII Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Human Coagulation Factor VIII Revenue by Region (2019-2024)
7.1.3 Global Human Coagulation Factor VIII Revenue by Region (2025-2030)
7.1.4 Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Human Coagulation Factor VIII Revenue (2019-2030)
7.2.2 North America Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Human Coagulation Factor VIII Revenue (2019-2030)
7.3.2 Europe Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Human Coagulation Factor VIII Revenue (2019-2030)
7.4.2 Asia-Pacific Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Human Coagulation Factor VIII Revenue (2019-2030)
7.5.2 LAMEA Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Shire (Baxter)
8.1.1 Shire (Baxter) Comapny Information
8.1.2 Shire (Baxter) Business Overview
8.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
8.1.5 Shire (Baxter) Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
8.2.5 Bayer Recent Developments
8.3 CSL
8.3.1 CSL Comapny Information
8.3.2 CSL Business Overview
8.3.3 CSL Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 CSL Human Coagulation Factor VIII Product Portfolio
8.3.5 CSL Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Grifols
8.5.1 Grifols Comapny Information
8.5.2 Grifols Business Overview
8.5.3 Grifols Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
8.5.5 Grifols Recent Developments
8.6 Biogen
8.6.1 Biogen Comapny Information
8.6.2 Biogen Business Overview
8.6.3 Biogen Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
8.6.5 Biogen Recent Developments
8.7 Octapharma
8.7.1 Octapharma Comapny Information
8.7.2 Octapharma Business Overview
8.7.3 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
8.7.5 Octapharma Recent Developments
8.8 NovoNordisk
8.8.1 NovoNordisk Comapny Information
8.8.2 NovoNordisk Business Overview
8.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
8.8.5 NovoNordisk Recent Developments
8.9 Greencross
8.9.1 Greencross Comapny Information
8.9.2 Greencross Business Overview
8.9.3 Greencross Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
8.9.5 Greencross Recent Developments
8.10 Kedrion
8.10.1 Kedrion Comapny Information
8.10.2 Kedrion Business Overview
8.10.3 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
8.10.5 Kedrion Recent Developments
8.11 BPL
8.11.1 BPL Comapny Information
8.11.2 BPL Business Overview
8.11.3 BPL Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 BPL Human Coagulation Factor VIII Product Portfolio
8.11.5 BPL Recent Developments
8.12 Hualan Bio
8.12.1 Hualan Bio Comapny Information
8.12.2 Hualan Bio Business Overview
8.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
8.12.5 Hualan Bio Recent Developments
8.13 RAAS
8.13.1 RAAS Comapny Information
8.13.2 RAAS Business Overview
8.13.3 RAAS Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
8.13.5 RAAS Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Human Coagulation Factor VIII Value Chain Analysis
9.1.1 Human Coagulation Factor VIII Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Coagulation Factor VIII Production Mode & Process
9.2 Human Coagulation Factor VIII Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Coagulation Factor VIII Distributors
9.2.3 Human Coagulation Factor VIII Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Human Coagulation Factor VIII Market Size, 2019 VS 2023 VS 2030
1.3 Global Human Coagulation Factor VIII Market Size Estimates and Forecasts (2019-2030)
1.4 Global Human Coagulation Factor VIII Sales Estimates and Forecasts (2019-2030)
1.5 Global Human Coagulation Factor VIII Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL HUMAN COAGULATION FACTOR VIII MARKET DYNAMICS
2.1 Human Coagulation Factor VIII Industry Trends
2.2 Human Coagulation Factor VIII Industry Drivers
2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
2.4 Human Coagulation Factor VIII Industry Restraints
3 HUMAN COAGULATION FACTOR VIII MARKET BY MANUFACTURERS
3.1 Global Human Coagulation Factor VIII Revenue by Manufacturers (2019-2024)
3.2 Global Human Coagulation Factor VIII Sales by Manufacturers (2019-2024)
3.3 Global Human Coagulation Factor VIII Average Sales Price by Manufacturers (2019-2024)
3.4 Global Human Coagulation Factor VIII Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
3.7 Global Human Coagulation Factor VIII Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Coagulation Factor VIII Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2023
3.8.3 2023 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier
4 HUMAN COAGULATION FACTOR VIII MARKET BY TYPE
4.1 Human Coagulation Factor VIII Type Introduction
4.1.1 Recombinant Factor VIII
4.1.2 Plasma-derived Factor VIII
4.2 Global Human Coagulation Factor VIII Sales by Type
4.2.1 Global Human Coagulation Factor VIII Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Coagulation Factor VIII Sales by Type (2019-2030)
4.2.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)
4.3 Global Human Coagulation Factor VIII Revenue by Type
4.3.1 Global Human Coagulation Factor VIII Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Coagulation Factor VIII Revenue by Type (2019-2030)
4.3.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)
5 HUMAN COAGULATION FACTOR VIII MARKET BY APPLICATION
5.1 Human Coagulation Factor VIII Application Introduction
5.1.1 Hemophilia A
5.1.2 Spontanous / Trauma
5.1.3 Surgical
5.1.4 Other
5.2 Global Human Coagulation Factor VIII Sales by Application
5.2.1 Global Human Coagulation Factor VIII Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Coagulation Factor VIII Sales by Application (2019-2030)
5.2.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)
5.3 Global Human Coagulation Factor VIII Revenue by Application
5.3.1 Global Human Coagulation Factor VIII Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Coagulation Factor VIII Revenue by Application (2019-2030)
5.3.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)
6 GLOBAL HUMAN COAGULATION FACTOR VIII SALES BY REGION
6.1 Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Coagulation Factor VIII Sales by Region (2019-2030)
6.2.1 Global Human Coagulation Factor VIII Sales by Region (2019-2024)
6.2.2 Global Human Coagulation Factor VIII Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Human Coagulation Factor VIII Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Human Coagulation Factor VIII Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Human Coagulation Factor VIII Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Human Coagulation Factor VIII Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL HUMAN COAGULATION FACTOR VIII REVENUE BY REGION
7.1 Global Human Coagulation Factor VIII Revenue by Region
7.1.1 Global Human Coagulation Factor VIII Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Human Coagulation Factor VIII Revenue by Region (2019-2024)
7.1.3 Global Human Coagulation Factor VIII Revenue by Region (2025-2030)
7.1.4 Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Human Coagulation Factor VIII Revenue (2019-2030)
7.2.2 North America Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Human Coagulation Factor VIII Revenue (2019-2030)
7.3.2 Europe Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Human Coagulation Factor VIII Revenue (2019-2030)
7.4.2 Asia-Pacific Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Human Coagulation Factor VIII Revenue (2019-2030)
7.5.2 LAMEA Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Shire (Baxter)
8.1.1 Shire (Baxter) Comapny Information
8.1.2 Shire (Baxter) Business Overview
8.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
8.1.5 Shire (Baxter) Recent Developments
8.2 Bayer
8.2.1 Bayer Comapny Information
8.2.2 Bayer Business Overview
8.2.3 Bayer Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
8.2.5 Bayer Recent Developments
8.3 CSL
8.3.1 CSL Comapny Information
8.3.2 CSL Business Overview
8.3.3 CSL Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 CSL Human Coagulation Factor VIII Product Portfolio
8.3.5 CSL Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Grifols
8.5.1 Grifols Comapny Information
8.5.2 Grifols Business Overview
8.5.3 Grifols Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
8.5.5 Grifols Recent Developments
8.6 Biogen
8.6.1 Biogen Comapny Information
8.6.2 Biogen Business Overview
8.6.3 Biogen Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
8.6.5 Biogen Recent Developments
8.7 Octapharma
8.7.1 Octapharma Comapny Information
8.7.2 Octapharma Business Overview
8.7.3 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
8.7.5 Octapharma Recent Developments
8.8 NovoNordisk
8.8.1 NovoNordisk Comapny Information
8.8.2 NovoNordisk Business Overview
8.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
8.8.5 NovoNordisk Recent Developments
8.9 Greencross
8.9.1 Greencross Comapny Information
8.9.2 Greencross Business Overview
8.9.3 Greencross Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
8.9.5 Greencross Recent Developments
8.10 Kedrion
8.10.1 Kedrion Comapny Information
8.10.2 Kedrion Business Overview
8.10.3 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
8.10.5 Kedrion Recent Developments
8.11 BPL
8.11.1 BPL Comapny Information
8.11.2 BPL Business Overview
8.11.3 BPL Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 BPL Human Coagulation Factor VIII Product Portfolio
8.11.5 BPL Recent Developments
8.12 Hualan Bio
8.12.1 Hualan Bio Comapny Information
8.12.2 Hualan Bio Business Overview
8.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
8.12.5 Hualan Bio Recent Developments
8.13 RAAS
8.13.1 RAAS Comapny Information
8.13.2 RAAS Business Overview
8.13.3 RAAS Human Coagulation Factor VIII Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
8.13.5 RAAS Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Human Coagulation Factor VIII Value Chain Analysis
9.1.1 Human Coagulation Factor VIII Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Coagulation Factor VIII Production Mode & Process
9.2 Human Coagulation Factor VIII Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Coagulation Factor VIII Distributors
9.2.3 Human Coagulation Factor VIII Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Human Coagulation Factor VIII Industry Trends
Table 2. Human Coagulation Factor VIII Industry Drivers
Table 3. Human Coagulation Factor VIII Industry Opportunities and Challenges
Table 4. Human Coagulation Factor VIII Industry Restraints
Table 5. Global Human Coagulation Factor VIII Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Human Coagulation Factor VIII Sales by Manufacturers (K Bottles) & (2019-2024)
Table 8. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers
Table 9. Global Human Coagulation Factor VIII Average Sales Price (USD/Bottle) of Manufacturers (2019-2024)
Table 10. Global Human Coagulation Factor VIII Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
Table 13. Global Human Coagulation Factor VIII Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Human Coagulation Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Recombinant Factor VIII
Table 17. Major Manufacturers of Plasma-derived Factor VIII
Table 18. Global Human Coagulation Factor VIII Sales by Type 2019 VS 2023 VS 2030 (K Bottles)
Table 19. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 20. Global Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 21. Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)
Table 22. Global Human Coagulation Factor VIII Sales Market Share by Type (2025-2030)
Table 23. Global Human Coagulation Factor VIII Revenue by Type 2019 VS 2023 VS 2030 (K Bottles)
Table 24. Global Human Coagulation Factor VIII Revenue by Type (2019-2024) & (K Bottles)
Table 25. Global Human Coagulation Factor VIII Revenue by Type (2025-2030) & (K Bottles)
Table 26. Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2024)
Table 27. Global Human Coagulation Factor VIII Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of Hemophilia A
Table 29. Major Manufacturers of Spontanous / Trauma
Table 30. Major Manufacturers of Surgical
Table 31. Major Manufacturers of Other
Table 32. Global Human Coagulation Factor VIII Sales by Application 2019 VS 2023 VS 2030 (K Bottles)
Table 33. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 34. Global Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 35. Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)
Table 36. Global Human Coagulation Factor VIII Sales Market Share by Application (2025-2030)
Table 37. Global Human Coagulation Factor VIII Revenue by Application 2019 VS 2023 VS 2030 (K Bottles)
Table 38. Global Human Coagulation Factor VIII Revenue by Application (2019-2024) & (K Bottles)
Table 39. Global Human Coagulation Factor VIII Revenue by Application (2025-2030) & (K Bottles)
Table 40. Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2024)
Table 41. Global Human Coagulation Factor VIII Revenue Market Share by Application (2025-2030)
Table 42. Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030 (K Bottles)
Table 43. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)
Table 44. Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2024)
Table 45. Global Human Coagulation Factor VIII Sales Forecasted by Region (2025-2030) & (K Bottles)
Table 46. Global Human Coagulation Factor VIII Sales Forecasted Market Share by Region (2025-2030)
Table 47. North America Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 48. North America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 49. North America Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 50. Europe Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 51. Europe Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 52. Europe Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 53. Asia Pacific Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 54. Asia Pacific Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 55. Asia Pacific Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 56. LAMEA Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 57. LAMEA Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 58. LAMEA Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 59. Global Human Coagulation Factor VIII Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. Global Human Coagulation Factor VIII Revenue by Region (2019-2024) & (US$ Million)
Table 61. Global Human Coagulation Factor VIII Revenue by Region (2025-2030) & (US$ Million)
Table 62. Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2024)
Table 63. Global Human Coagulation Factor VIII Revenue Market Share by Region (2025-2030)
Table 64. Shire (Baxter) Company Information
Table 65. Shire (Baxter) Business Overview
Table 66. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 67. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 68. Shire (Baxter) Recent Development
Table 69. Bayer Company Information
Table 70. Bayer Business Overview
Table 71. Bayer Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. Bayer Human Coagulation Factor VIII Product Portfolio
Table 73. Bayer Recent Development
Table 74. CSL Company Information
Table 75. CSL Business Overview
Table 76. CSL Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. CSL Human Coagulation Factor VIII Product Portfolio
Table 78. CSL Recent Development
Table 79. Pfizer Company Information
Table 80. Pfizer Business Overview
Table 81. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 82. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 83. Pfizer Recent Development
Table 84. Grifols Company Information
Table 85. Grifols Business Overview
Table 86. Grifols Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 87. Grifols Human Coagulation Factor VIII Product Portfolio
Table 88. Grifols Recent Development
Table 89. Biogen Company Information
Table 90. Biogen Business Overview
Table 91. Biogen Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 92. Biogen Human Coagulation Factor VIII Product Portfolio
Table 93. Biogen Recent Development
Table 94. Octapharma Company Information
Table 95. Octapharma Business Overview
Table 96. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 97. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 98. Octapharma Recent Development
Table 99. NovoNordisk Company Information
Table 100. NovoNordisk Business Overview
Table 101. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 102. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 103. NovoNordisk Recent Development
Table 104. Greencross Company Information
Table 105. Greencross Business Overview
Table 106. Greencross Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 107. Greencross Human Coagulation Factor VIII Product Portfolio
Table 108. Greencross Recent Development
Table 109. Kedrion Company Information
Table 110. Kedrion Business Overview
Table 111. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 112. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 113. Kedrion Recent Development
Table 114. BPL Company Information
Table 115. BPL Business Overview
Table 116. BPL Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 117. BPL Human Coagulation Factor VIII Product Portfolio
Table 118. BPL Recent Development
Table 119. Hualan Bio Company Information
Table 120. Hualan Bio Business Overview
Table 121. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 122. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 123. Hualan Bio Recent Development
Table 124. RAAS Company Information
Table 125. RAAS Business Overview
Table 126. RAAS Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 127. RAAS Human Coagulation Factor VIII Product Portfolio
Table 128. RAAS Recent Development
Table 129. Key Raw Materials
Table 130. Raw Materials Key Suppliers
Table 131. Human Coagulation Factor VIII Distributors List
Table 132. Human Coagulation Factor VIII Customers List
Table 133. Research Programs/Design for This Report
Table 134. Authors List of This Report
Table 135. Secondary Sources
Table 136. Primary Sources
Table 1. Human Coagulation Factor VIII Industry Trends
Table 2. Human Coagulation Factor VIII Industry Drivers
Table 3. Human Coagulation Factor VIII Industry Opportunities and Challenges
Table 4. Human Coagulation Factor VIII Industry Restraints
Table 5. Global Human Coagulation Factor VIII Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Human Coagulation Factor VIII Sales by Manufacturers (K Bottles) & (2019-2024)
Table 8. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers
Table 9. Global Human Coagulation Factor VIII Average Sales Price (USD/Bottle) of Manufacturers (2019-2024)
Table 10. Global Human Coagulation Factor VIII Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
Table 13. Global Human Coagulation Factor VIII Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Human Coagulation Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Recombinant Factor VIII
Table 17. Major Manufacturers of Plasma-derived Factor VIII
Table 18. Global Human Coagulation Factor VIII Sales by Type 2019 VS 2023 VS 2030 (K Bottles)
Table 19. Global Human Coagulation Factor VIII Sales by Type (2019-2024) & (K Bottles)
Table 20. Global Human Coagulation Factor VIII Sales by Type (2025-2030) & (K Bottles)
Table 21. Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2024)
Table 22. Global Human Coagulation Factor VIII Sales Market Share by Type (2025-2030)
Table 23. Global Human Coagulation Factor VIII Revenue by Type 2019 VS 2023 VS 2030 (K Bottles)
Table 24. Global Human Coagulation Factor VIII Revenue by Type (2019-2024) & (K Bottles)
Table 25. Global Human Coagulation Factor VIII Revenue by Type (2025-2030) & (K Bottles)
Table 26. Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2024)
Table 27. Global Human Coagulation Factor VIII Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of Hemophilia A
Table 29. Major Manufacturers of Spontanous / Trauma
Table 30. Major Manufacturers of Surgical
Table 31. Major Manufacturers of Other
Table 32. Global Human Coagulation Factor VIII Sales by Application 2019 VS 2023 VS 2030 (K Bottles)
Table 33. Global Human Coagulation Factor VIII Sales by Application (2019-2024) & (K Bottles)
Table 34. Global Human Coagulation Factor VIII Sales by Application (2025-2030) & (K Bottles)
Table 35. Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2024)
Table 36. Global Human Coagulation Factor VIII Sales Market Share by Application (2025-2030)
Table 37. Global Human Coagulation Factor VIII Revenue by Application 2019 VS 2023 VS 2030 (K Bottles)
Table 38. Global Human Coagulation Factor VIII Revenue by Application (2019-2024) & (K Bottles)
Table 39. Global Human Coagulation Factor VIII Revenue by Application (2025-2030) & (K Bottles)
Table 40. Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2024)
Table 41. Global Human Coagulation Factor VIII Revenue Market Share by Application (2025-2030)
Table 42. Global Human Coagulation Factor VIII Sales by Region: 2019 VS 2023 VS 2030 (K Bottles)
Table 43. Global Human Coagulation Factor VIII Sales by Region (2019-2024) & (K Bottles)
Table 44. Global Human Coagulation Factor VIII Sales Market Share by Region (2019-2024)
Table 45. Global Human Coagulation Factor VIII Sales Forecasted by Region (2025-2030) & (K Bottles)
Table 46. Global Human Coagulation Factor VIII Sales Forecasted Market Share by Region (2025-2030)
Table 47. North America Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 48. North America Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 49. North America Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 50. Europe Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 51. Europe Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 52. Europe Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 53. Asia Pacific Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 54. Asia Pacific Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 55. Asia Pacific Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 56. LAMEA Human Coagulation Factor VIII Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Bottles)
Table 57. LAMEA Human Coagulation Factor VIII Sales by Country (2019-2024) & (K Bottles)
Table 58. LAMEA Human Coagulation Factor VIII Sales by Country (2025-2030) & (K Bottles)
Table 59. Global Human Coagulation Factor VIII Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. Global Human Coagulation Factor VIII Revenue by Region (2019-2024) & (US$ Million)
Table 61. Global Human Coagulation Factor VIII Revenue by Region (2025-2030) & (US$ Million)
Table 62. Global Human Coagulation Factor VIII Revenue Market Share by Region (2019-2024)
Table 63. Global Human Coagulation Factor VIII Revenue Market Share by Region (2025-2030)
Table 64. Shire (Baxter) Company Information
Table 65. Shire (Baxter) Business Overview
Table 66. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 67. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
Table 68. Shire (Baxter) Recent Development
Table 69. Bayer Company Information
Table 70. Bayer Business Overview
Table 71. Bayer Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. Bayer Human Coagulation Factor VIII Product Portfolio
Table 73. Bayer Recent Development
Table 74. CSL Company Information
Table 75. CSL Business Overview
Table 76. CSL Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. CSL Human Coagulation Factor VIII Product Portfolio
Table 78. CSL Recent Development
Table 79. Pfizer Company Information
Table 80. Pfizer Business Overview
Table 81. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 82. Pfizer Human Coagulation Factor VIII Product Portfolio
Table 83. Pfizer Recent Development
Table 84. Grifols Company Information
Table 85. Grifols Business Overview
Table 86. Grifols Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 87. Grifols Human Coagulation Factor VIII Product Portfolio
Table 88. Grifols Recent Development
Table 89. Biogen Company Information
Table 90. Biogen Business Overview
Table 91. Biogen Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 92. Biogen Human Coagulation Factor VIII Product Portfolio
Table 93. Biogen Recent Development
Table 94. Octapharma Company Information
Table 95. Octapharma Business Overview
Table 96. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 97. Octapharma Human Coagulation Factor VIII Product Portfolio
Table 98. Octapharma Recent Development
Table 99. NovoNordisk Company Information
Table 100. NovoNordisk Business Overview
Table 101. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 102. NovoNordisk Human Coagulation Factor VIII Product Portfolio
Table 103. NovoNordisk Recent Development
Table 104. Greencross Company Information
Table 105. Greencross Business Overview
Table 106. Greencross Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 107. Greencross Human Coagulation Factor VIII Product Portfolio
Table 108. Greencross Recent Development
Table 109. Kedrion Company Information
Table 110. Kedrion Business Overview
Table 111. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 112. Kedrion Human Coagulation Factor VIII Product Portfolio
Table 113. Kedrion Recent Development
Table 114. BPL Company Information
Table 115. BPL Business Overview
Table 116. BPL Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 117. BPL Human Coagulation Factor VIII Product Portfolio
Table 118. BPL Recent Development
Table 119. Hualan Bio Company Information
Table 120. Hualan Bio Business Overview
Table 121. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 122. Hualan Bio Human Coagulation Factor VIII Product Portfolio
Table 123. Hualan Bio Recent Development
Table 124. RAAS Company Information
Table 125. RAAS Business Overview
Table 126. RAAS Human Coagulation Factor VIII Sales (K Bottles), Price (USD/Bottle), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 127. RAAS Human Coagulation Factor VIII Product Portfolio
Table 128. RAAS Recent Development
Table 129. Key Raw Materials
Table 130. Raw Materials Key Suppliers
Table 131. Human Coagulation Factor VIII Distributors List
Table 132. Human Coagulation Factor VIII Customers List
Table 133. Research Programs/Design for This Report
Table 134. Authors List of This Report
Table 135. Secondary Sources
Table 136. Primary Sources
LIST OF FIGURES
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Coagulation Factor VIII Market Size (2019-2030) & (US$ Million)
Figure 4. Global Human Coagulation Factor VIII Sales (2019-2030) & (K Bottles)
Figure 5. Global Human Coagulation Factor VIII Average Price (USD/Bottle) & (2019-2030)
Figure 6. Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Recombinant Factor VIII Picture
Figure 9. Plasma-derived Factor VIII Picture
Figure 10. Global Human Coagulation Factor VIII Sales by Type (2019 VS 2023 VS 2030) & (K Bottles)
Figure 11. Global Human Coagulation Factor VIII Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)
Figure 13. Global Human Coagulation Factor VIII Revenue by Type (2019 VS 2023 VS 2030) & (K Bottles)
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)
Figure 16. Hemophilia A Picture
Figure 17. Spontanous / Trauma Picture
Figure 18. Surgical Picture
Figure 19. Other Picture
Figure 20. Global Human Coagulation Factor VIII Sales by Application (2019 VS 2023 VS 2030) & (K Bottles)
Figure 21. Global Human Coagulation Factor VIII Sales Market Share 2019 VS 2023 VS 2030
Figure 22. Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)
Figure 23. Global Human Coagulation Factor VIII Revenue by Application (2019 VS 2023 VS 2030) & (K Bottles)
Figure 24. Global Human Coagulation Factor VIII Revenue Market Share 2019 VS 2023 VS 2030
Figure 25. Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)
Figure 26. North America Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 27. North America Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)
Figure 28. U.S. Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 29. Canada Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 30. Europe Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 31. Europe Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)
Figure 32. Germany Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 33. France Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 34. U.K. Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 35. Italy Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 36. Netherlands Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 37. Asia Pacific Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 38. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)
Figure 39. China Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 40. Japan Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 41. South Korea Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 42. Southeast Asia Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 43. India Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 44. Australia Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 45. LAMEA Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 46. LAMEA Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)
Figure 47. Mexico Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 48. Brazil Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 49. Turkey Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 50. GCC Countries Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 51. Global Human Coagulation Factor VIII Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Global Human Coagulation Factor VIII Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 53. North America Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Figure 54. North America Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 55. Europe Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Figure 56. Europe Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. Asia-Pacific Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Figure 58. Asia-Pacific Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. LAMEA Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Figure 60. LAMEA Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 61. Human Coagulation Factor VIII Value Chain
Figure 62. Manufacturing Cost Structure
Figure 63. Human Coagulation Factor VIII Production Mode & Process
Figure 64. Direct Comparison with Distribution Share
Figure 65. Distributors Profiles
Figure 66. Years Considered
Figure 67. Research Process
Figure 68. Key Executives Interviewed
Figure 1. Human Coagulation Factor VIII Product Picture
Figure 2. Global Human Coagulation Factor VIII Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Human Coagulation Factor VIII Market Size (2019-2030) & (US$ Million)
Figure 4. Global Human Coagulation Factor VIII Sales (2019-2030) & (K Bottles)
Figure 5. Global Human Coagulation Factor VIII Average Price (USD/Bottle) & (2019-2030)
Figure 6. Global Top 5 and 10 Human Coagulation Factor VIII Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Recombinant Factor VIII Picture
Figure 9. Plasma-derived Factor VIII Picture
Figure 10. Global Human Coagulation Factor VIII Sales by Type (2019 VS 2023 VS 2030) & (K Bottles)
Figure 11. Global Human Coagulation Factor VIII Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Human Coagulation Factor VIII Sales Market Share by Type (2019-2030)
Figure 13. Global Human Coagulation Factor VIII Revenue by Type (2019 VS 2023 VS 2030) & (K Bottles)
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Human Coagulation Factor VIII Revenue Market Share by Type (2019-2030)
Figure 16. Hemophilia A Picture
Figure 17. Spontanous / Trauma Picture
Figure 18. Surgical Picture
Figure 19. Other Picture
Figure 20. Global Human Coagulation Factor VIII Sales by Application (2019 VS 2023 VS 2030) & (K Bottles)
Figure 21. Global Human Coagulation Factor VIII Sales Market Share 2019 VS 2023 VS 2030
Figure 22. Global Human Coagulation Factor VIII Sales Market Share by Application (2019-2030)
Figure 23. Global Human Coagulation Factor VIII Revenue by Application (2019 VS 2023 VS 2030) & (K Bottles)
Figure 24. Global Human Coagulation Factor VIII Revenue Market Share 2019 VS 2023 VS 2030
Figure 25. Global Human Coagulation Factor VIII Revenue Market Share by Application (2019-2030)
Figure 26. North America Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 27. North America Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)
Figure 28. U.S. Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 29. Canada Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 30. Europe Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 31. Europe Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)
Figure 32. Germany Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 33. France Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 34. U.K. Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 35. Italy Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 36. Netherlands Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 37. Asia Pacific Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 38. Asia Pacific Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)
Figure 39. China Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 40. Japan Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 41. South Korea Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 42. Southeast Asia Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 43. India Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 44. Australia Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 45. LAMEA Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 46. LAMEA Human Coagulation Factor VIII Sales Market Share by Country (2019-2030)
Figure 47. Mexico Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 48. Brazil Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 49. Turkey Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 50. GCC Countries Human Coagulation Factor VIII Sales and Growth Rate (2019-2030) & (K Bottles)
Figure 51. Global Human Coagulation Factor VIII Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Global Human Coagulation Factor VIII Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 53. North America Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Figure 54. North America Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 55. Europe Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Figure 56. Europe Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 57. Asia-Pacific Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Figure 58. Asia-Pacific Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 59. LAMEA Human Coagulation Factor VIII Revenue (2019-2030) & (US$ Million)
Figure 60. LAMEA Human Coagulation Factor VIII Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 61. Human Coagulation Factor VIII Value Chain
Figure 62. Manufacturing Cost Structure
Figure 63. Human Coagulation Factor VIII Production Mode & Process
Figure 64. Direct Comparison with Distribution Share
Figure 65. Distributors Profiles
Figure 66. Years Considered
Figure 67. Research Process
Figure 68. Key Executives Interviewed
